MAYD Group

About MAYD Group

Berlin-based MAYD Group GmbH, operating as Meds At Your Doorstep, is a health-tech firm focused on revolutionizing pharmacy services in Europe. Established in 2021 by serial entrepreneurs Lukas Pieczonka and Hanno Heintzenberg, the company has rapidly positioned itself within the on-demand delivery market. The founders' prior entrepreneurial experience, including Pieczonka's co-founding of McMakler, provided a strong foundation for MAYD's ambitious growth strategy. The company's core service is the rapid delivery of medications and healthcare products from local pharmacies to consumers' homes, promising a delivery window of just 30 minutes, 365 days a year.

MAYD's business model hinges on creating a digital bridge between customers and their neighborhood pharmacies. Revenue is generated by charging partner pharmacies a platform fee, rather than imposing delivery charges or minimum order values on the end consumer. This B2B2C approach allows pharmacies to extend their reach and compete in the digital economy while enabling customers to receive non-prescription products, get pharmacist advice via the platform, and eventually, process e-prescriptions. The product catalog is extensive, offering access to over 2,000 different healthcare-related items.

The company demonstrated significant traction early on, securing a total of $48.9 million (€43 million) in capital across two funding rounds within months of its launch. A Seed round in October 2021 raised $15 million, followed by a substantial $33.8 million Series A round in January 2022. This Series A was led by Lightspeed Venture Partners and saw participation from existing investors including Target Global, 468 Capital, and Earlybird Venture Capital. These funds have been allocated to fuel aggressive expansion across Germany—from its initial launch in Berlin to cities like Hamburg, Munich, and Frankfurt—and to prepare for entry into other European markets.